Venus Concept to Release Third Quarter of Fiscal Year 2020 Financial Results on November 16, 2020

Rhea-AI Summary

Venus Concept (NASDAQ: VERO) will announce its Q3 fiscal 2020 financial results on November 16, 2020, before market opening. The management will host a conference call at 8:00 a.m. ET on the same day to discuss the results, followed by a Q&A session. Those interested can join via phone or listen through a live webcast available on their investor relations website. Venus Concept operates in over 60 countries, offering a diverse portfolio of medical aesthetic technologies and hair restoration systems, focusing on a subscription-based sales strategy.

Positive

• Venus Concept operates in over 60 countries, enhancing market reach.
• The company has a diverse portfolio with 10 aesthetic device platforms.
• Strong backing from prominent healthcare investors like EW Healthcare Partners.

Negative

• None.

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of fiscal year 2020 financial results will be released before the market opens on Monday, November 16, 2020.

Management will host a conference call at 8:00 a.m. Eastern Time on November 16, 2020 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13711300. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.

For those unable to participate, a replay of the call will be available for two weeks at 877-660-6853 (201-612-7415 for international callers); access code 13711300. The webcast will be archived at ir.venusconcept.com.

About Venus Concept

Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reach in over 60 countries and 29 direct markets. Venus Concept focuses its product sales strategy on a subscription-based business model in North America and in its well-established direct global markets. Venus Concept’s product portfolio consists of 10 aesthetic device platforms, including Venus Versa, Venus Legacy, Venus Velocity, Venus Fiore, Venus Viva, Venus Freeze Plus, and Venus Bliss. Venus Concept’s hair restoration systems includes NeoGraft®, an automated hair restoration system that facilitates the harvesting of follicles during a FUE process and the ARTAS® and ARTAS iX® Robotic Hair Restoration systems, which harvest follicular units directly from the scalp and create recipient implant sites using proprietary algorithms. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, and Aperture Venture Partners.

FAQ

When will Venus Concept announce its Q3 financial results?

Venus Concept will announce its Q3 financial results on November 16, 2020, before market opens.

What time will Venus Concept's conference call take place?

The conference call will take place at 8:00 a.m. Eastern Time on November 16, 2020.

How can I participate in Venus Concept's conference call?

To participate in the conference call, dial 877-407-2991 (or 201-389-0925 for international callers) and provide access code 13711300.

Where can I find the replay of Venus Concept's conference call?

The replay of the conference call will be available for two weeks at 877-660-6853 (or 201-612-7415 for international callers) with access code 13711300.